EGF and cancer: One possibility may be autocrine activation of these receptors due to the expression of a ligand, such as EGF or HGF etc. The expression of ligand by cancer cells has been observed in many cases that often lead to drug resistance bypassing a need for the overexpression or activating mutation in oncogenes for cancer progression.